Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy.
Kieran F DochertyPardeep S JhundOlof BengtssonDavid L DeMetsCatherine M ViscoliLars KøberMikhail Naum KosiborodAnna Maria LangkildeFelipe A MartinezMarc S SabatineMikaela SjöstrandScott D SolomonJohn Joseph Valentine McMurraynull nullPublished in: Diabetes care (2020)
In DAPA-HF, dapagliflozin improved outcomes irrespective of use or no use of GLT or by GLT type used in patients with type 2 diabetes and HFrEF.